BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25725236)

  • 1. Current ESRD burden and its future trend in Beijing, China.
    Gan L; Zuo L
    Clin Nephrol; 2015; 83(7 Suppl 1):17-20. PubMed ID: 25725236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current burden of end-stage kidney disease and its future trend in China.
    Zhang L; Zuo L
    Clin Nephrol; 2016 Supplement 1; 86 (2016)(13):27-28. PubMed ID: 27469147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of hemodialysis treatment in Beijing, China.
    Zuo L; Wang M;
    Ethn Dis; 2006; 16(2 Suppl 2):S2-31-4. PubMed ID: 16774007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of maintenance hemodialysis in Beijing, China.
    Zuo L; Wang M;
    Kidney Int Suppl (2011); 2013 May; 3(2):167-169. PubMed ID: 25018982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology investigation and analysis of patients with hemodialysis in Sichuan province of China.
    Zou Y; Hong D; He Q; Wen Y; Li G
    Ren Fail; 2019 Nov; 41(1):644-649. PubMed ID: 31296088
    [No Abstract]   [Full Text] [Related]  

  • 6. Burden of disease: prevalence and incidence of ESRD in Latin America.
    Gonzalez-Bedat M; Rosa-Diez G; Pecoits-Filho R; Ferreiro A; García-García G; Cusumano A; Fernandez-Cean J; Noboa O; Douthat W
    Clin Nephrol; 2015; 83(7 Suppl 1):3-6. PubMed ID: 25725232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality rates among prevalent hemodialysis patients in Beijing: a comparison with USRDS data.
    Cheng X; Nayyar S; Wang M; Li X; Sun Y; Huang W; Zhang L; Wu H; Jia Q; Liu W; Sun X; Li J; Lun L; Zhou C; Cui T; Zhang A; Wang K; Wang S; Sun W; Zuo L
    Nephrol Dial Transplant; 2013 Mar; 28(3):724-32. PubMed ID: 22907953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forecast of the incidence, prevalence and burden of end-stage renal disease in Nanjing, China to the Year 2025.
    Sun L; Zou LX; Han YC; Huang HM; Tan ZM; Gao M; Ma KL; Liu H; Liu BC
    BMC Nephrol; 2016 Jun; 17(1):60. PubMed ID: 27295981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological analysis of death among patients on maintenance hemodialysis: results from the beijing blood purification quality Control and Improvement Center.
    Liu J; Zhang H; Diao Z; Guo W; Huang H; Zuo L; Liu W
    BMC Nephrol; 2023 Aug; 24(1):236. PubMed ID: 37582779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
    G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Etiologic and relevant factor analysis of 1,622 ESRD patients with hemodialysis in Hunan province].
    Peng YM; Liu H; Liu FY
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 31(3):400-3. PubMed ID: 16859133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden of end-stage renal disease (ESRD) in Latin America.
    Rosa-Diez G; Gonzalez-Bedat M; Ferreiro A; García-García G; Fernandez-Cean J; Douthat W
    Clin Nephrol; 2016 Supplement 1; 86 (2016)(13):29-33. PubMed ID: 27509582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current burden and probable increasing incidence of ESRD in China.
    Zuo L; Wang M;
    Clin Nephrol; 2010 Nov; 74 Suppl 1():S20-2. PubMed ID: 20979958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early mortality risk in incident Chinese hemodialysis patients: a retrospective cohort study.
    Zhao X; Wang M; Zuo L
    Ren Fail; 2017 Nov; 39(1):526-532. PubMed ID: 28635363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of end-stage renal disease care in South Asia.
    Jha V
    Ethn Dis; 2009; 19(1 Suppl 1):S1-27-32. PubMed ID: 19484871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The growing burden of end-stage renal disease in Egypt.
    Soliman AR; Fathy A; Roshd D
    Ren Fail; 2012; 34(4):425-8. PubMed ID: 22260432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal replacement therapy among disadvantaged populations in Mexico: a report from the Jalisco Dialysis and Transplant Registry (REDTJAL).
    Garcia-Garcia G; Monteon-Ramos JF; Garcia-Bejarano H; Gomez-Navarro B; Reyes IH; Lomeli AM; Palomeque M; Cortes-Sanabria L; Breien-Alcaraz H; Ruiz-Morales NM
    Kidney Int Suppl; 2005 Aug; (97):S58-61. PubMed ID: 16014102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes-related end-stage renal disease in Austria 1965-2013.
    Prischl FC; Auinger M; Säemann M; Mayer G; Rosenkranz AR; Wallner M; Kramar R;
    Nephrol Dial Transplant; 2015 Nov; 30(11):1920-7. PubMed ID: 25977308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. End-stage renal disease and its treatment in Latin America in the twenty-first century.
    Cusumano A; Garcia-Garcia G; Di Gioia C; Hermida O; Lavorato C; Carreño CA; Torrico MP; Batista PB; Romão JE; Badal HP; Miranda SE; Gomez R; Calderon MC; Sanchez SH; Lopez MA; Moscoso J; Merino RL; Polo JV; Lopez A; Romero NJ; Garcia R; Acosta BV; Lopez AS; Delpin ES; Mena E; González C; Milanés CL; Acchiardo S
    Ren Fail; 2006; 28(8):631-7. PubMed ID: 17162420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.